Brief: Gelesis Announces Partnership For Commercial Launch Of Plenity In China
June 18 (Reuters) - China Medical System Holdings Ltd
0867.HK :
* GELESIS ANNOUNCES PARTNERSHIP FOR COMMERCIAL LAUNCH OF
PLENITY
IN CHINA
* GELESIS - ANNOUNCED PARTNERSHIP WITH CHINA MEDICAL SYSTEM
HOLDINGS FOR COMMERCIALIZATION OF PLENITY IN CHINA
* GELESIS - CMS TO PROVIDE $35 MILLION UPFRONT IN LICENSING
FEES
AND EQUITY INVESTMENT WITH POTENTIAL FOR ADDITIONAL $388 MILLION
IN FUTURE MILESTONE PAYMENTS
Source text for Eikon: ID:nBw25yBtGa
Further company coverage: 0867.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Medical System Holdings
See all newsBrief: China Medical System Says CMS-D001 Granted Drug Clinical Trial Approval Notice By NMPA
Brief: China Medical System Holdings Says Dermavon Receives NMPA Approval For Lumirix NDA For Atopic Dermatitis
China Medical System climbs most in six weeks on higher profit, dividend
China Medical System H1 revenue rises on jump in sales of innovative and exclusive products
AI shortens drug discovery to around 1 year in China, Insilico CEO says